Rodart I, Pares M, Mendes A, Accardo C, Martins J, Silva C
Molecules. 2021; 26(13).
PMID: 34202190
PMC: 8270308.
DOI: 10.3390/molecules26133892.
Thakur V, Guptan R, Geeret M, Das B, Sarin S
EJIFCC. 2018; 14(3):133-140.
PMID: 30275814
PMC: 6156967.
Saleem A, Akhtar M, Mushtaq M, Saleem M, Muhammad S, Akhtar B
EXCLI J. 2017; 15:578-588.
PMID: 28096788
PMC: 5225681.
DOI: 10.17179/excli2016-582.
Livingston S, Townshend-Bulson L, Bruden D, Homan C, Gove J, Plotnik J
Int J Circumpolar Health. 2016; 75:30696.
PMID: 27029671
PMC: 4814572.
DOI: 10.3402/ijch.v75.30696.
Galdino A, Santos J, Souza M, Nobrega Y, Xavier M, Felipe M
Hepat Res Treat. 2016; 2016:6592143.
PMID: 26942007
PMC: 4749800.
DOI: 10.1155/2016/6592143.
Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10.
de Souza-Cruz S, Victoria M, Tarrago A, Costa A, Pimentel J, Pires E
BMC Microbiol. 2016; 16:3.
PMID: 26742960
PMC: 4705620.
DOI: 10.1186/s12866-015-0610-6.
Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.
Cunningham E, Applegate T, Lloyd A, Dore G, Grebely J
Nat Rev Gastroenterol Hepatol. 2015; 12(4):218-30.
PMID: 25782091
DOI: 10.1038/nrgastro.2015.36.
Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review.
Firdaus R, Saha K, Biswas A, Sadhukhan P
World J Virol. 2015; 4(1):25-32.
PMID: 25674515
PMC: 4308525.
DOI: 10.5501/wjv.v4.i1.25.
Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment.
Kanwal S, Mahmood T
Virol J. 2014; 11:171.
PMID: 25270660
PMC: 4289283.
DOI: 10.1186/1743-422X-11-171.
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
Wang X, Liu F, Wei F, Ren H, Hu H
PLoS One. 2014; 9(6):e100128.
PMID: 24963667
PMC: 4070902.
DOI: 10.1371/journal.pone.0100128.
Necessity for reassessment of patients with serogroup 2 hepatitis C virus (HCV) and undetectable serum HCV RNA.
Moritou Y, Ikeda F, Takeuchi Y, Seki H, Nanba S, Iwasaki Y
J Clin Microbiol. 2014; 52(2):544-8.
PMID: 24478486
PMC: 3911362.
DOI: 10.1128/JCM.02792-13.
Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes.
Rajhi M, Mejri S, Djebbi A, Chouaieb S, Cheikh I, Ben Yahia A
Virus Genes. 2013; 48(2):209-17.
PMID: 24272697
DOI: 10.1007/s11262-013-1010-3.
A new subtype of hepatitis C virus genotype 3: analysis of available evidence.
Salehi Moghadam F, Mohebbi S, Hosseini S, Damavand B, Zali M
Hepat Mon. 2013; 13(8):e13380.
PMID: 24098307
PMC: 3787683.
DOI: 10.5812/hepatmon.13380.
Identification of rare hepatitis C virus genotype 5a among Indian population.
Syed R, Satti V, Habeeb A, Khaja M
Virus Genes. 2013; 47(1):152-5.
PMID: 23575989
DOI: 10.1007/s11262-013-0905-3.
Molecular characterization of hepatitis c virus in multi-transfused Colombian patients.
Di Filippo D, Cortes-Mancera F, Beltran M, Patricia Arbelaez M, Jaramillo S, Restrepo J
Virol J. 2012; 9:242.
PMID: 23088845
PMC: 3544681.
DOI: 10.1186/1743-422X-9-242.
Molecular survey of hepatitis C virus in the touristic city of Mar del Plata, Argentina.
Culasso A, Elizalde M, Campos R, Barbini L
PLoS One. 2012; 7(9):e44757.
PMID: 23028605
PMC: 3454412.
DOI: 10.1371/journal.pone.0044757.
Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience.
Cho E, Jeong S, Han B, Lee S, Yun B, Park E
Clin Mol Hepatol. 2012; 18(2):219-24.
PMID: 22893873
PMC: 3415883.
DOI: 10.3350/cmh.2012.18.2.219.
Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan.
Kanwal S, Mahmood T
Hepat Mon. 2012; 12(6):398-407.
PMID: 22879830
PMC: 3412557.
DOI: 10.5812/hepatmon.6184.
Risk factors for infection with different hepatitis C virus genotypes in southern Brazil.
Paraboni M, Sbeghen M, Herz Wolff F, Moreira L
ScientificWorldJournal. 2012; 2012:946954.
PMID: 22666173
PMC: 3366236.
DOI: 10.1100/2012/946954.
Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection.
Livingston S, Townshend-Bulson L, Bruden D, McMahon B, Homan C, Gove J
Int J Circumpolar Health. 2012; 71:1-7.
PMID: 22564468
PMC: 3417585.
DOI: 10.3402/ijch.v71i0.18445.